SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cell Genesys, Inc. (NASDAQ:CEGE) today reported financial results for the second quarter 2009. The company reported a net loss of $3.8 million ($0.04 per fully diluted share), for the second quarter of 2009, compared to a net loss of $2.8 million ($0.03 per fully diluted share) for the corresponding period in 2008. The increase in net loss was primarily the result of recognizing non-cash losses in 2009 related to a warrant liability as compared to recognizing non-cash gains in 2008, partially offset by gains from the repurchase and exchange of convertible senior notes in 2009.
